Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Jul 2025 for Inozyme Pharma, Inc., €135k. Read the official filing
Filing timeline
BuySaleSanjay Subramanian
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sanjay Subramanian: trading record in brief
Sanjay Subramanian (finance chief) discloses dealings in 2 companies, chiefly Ocugen, Inc. and Inozyme Pharma, Inc. Between 29 April 2021 and 1 July 2025, the trades on record add up to 14 filings.
In open-market terms, that means 1 purchase worth €93k on one side and 1 sale worth €95k on the other. The net balance comes to €2,806 on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants and 6 option exercises.
The record was last updated on 3 July 2025 with a transaction (€135k) in Inozyme Pharma, Inc. The last insider purchase was made public on 20 April 2022, 1,642 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sanjay Subramanian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
39,701 shares@ US$4.0055.3% of flowCommon StockSEC:0000950170-25-094103:0
6,813 shares@ US$0.744.0% of flowCommon StockSEC:0000950170-25-090862:0
2,490 shares@ US$0.771.7% of flowCommon StockSEC:0000950170-25-049386:0
2,319 shares@ US$3.577.5% of flowCommon StockSEC:0001209191-23-051393:0
979 shares@ US$2.211.9% of flowCommon StockSEC:0001209191-23-022466:0
27,100 shares@ US$3.69100.0% of flowCommon StockSEC:0001209191-22-024916:0
Canonical exit: 18 Jul 2022 (T+90)
125,534 shares0Common StockSEC:0001062993-22-000700:0
10,000 shares@ US$11.0759.7% of flowCommon StockSEC:0001879785-21-000013:0
7,990 shares@ US$2.199.4% of flowCommon StockSEC:0001192482-21-000740:0
30,000 shares@ US$0.345.4% of flowCommon StockSEC:0001192482-21-000669:0
31,086 shares@ US$0.345.6% of flowCommon StockSEC:0001192482-21-000633:0
31,000 shares@ US$0.345.4% of flowCommon StockSEC:0001790246-21-000003:0
31,000 shares@ US$0.345.5% of flowCommon StockSEC:0001192482-21-000423:0
7,990 shares@ US$2.199.0% of flowCommon StockSEC:0001192482-21-000394:0
14 of 14 declarations
